80
Participants
Start Date
May 13, 2019
Primary Completion Date
June 1, 2024
Study Completion Date
December 31, 2024
64Cu-FBP8
Up to 10 mCi (millicurie) 64Cu-FBP8 will be administered to each subject.
PET-CT imaging
All subjects will undergo PET-CT imaging after administration of 64Cu-FBP8.
RECRUITING
Massachusetts General Hospital, Boston
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Peter Caravan
OTHER